Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2020-10-14 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
109年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors and senior management. It focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. The content aligns with reporting of personal share transactions or holdings by company directors and executives. There is no indication of a full financial report, earnings release, or meeting announcement. Therefore, the document fits best under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-10-14 Chinese
公告本公司買回庫藏股期間屆滿執行情形
Transaction in Own Shares Classification · 100% confidence The document is a company announcement regarding the completion status of a share buyback program, including details such as the number of shares repurchased, the price range, and reasons for not fully executing the buyback. It does not contain financial statements or detailed financial analysis but reports on the company's transaction in its own shares. This fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused solely on buyback execution details, confirming it is not a full financial report or an announcement of a report publication.
2020-10-08 Chinese
109年9月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report for a company named 景岳 for the period 民國109年09月 (September 2020). It contains monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and notes on accounting standards (IFRS) and reporting requirements. The document is short (769 characters) and primarily provides financial summary data without detailed financial statements or management discussion. It does not appear to be a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is more of a regulatory financial summary or disclosure. Given the nature and length, and that it is a financial summary report provided to a regulatory information platform, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory financial disclosures that do not fit other specific categories.
2020-10-07 Chinese
109年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory announcements, and no mention of any report publication or certification. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing. The document length is very short (601 characters), and it is not an announcement of a report publication but a direct disclosure. Therefore, it fits best under Regulatory Filings (RNS).
2020-10-07 Chinese
108年年報及股東會資料 — 2019_3164_20200630F11.pdf
Annual Report Classification · 100% confidence The document is titled as the '108年度年報' which translates to the '108th Fiscal Year Annual Report' for GenMont Biotech Inc. It includes detailed sections such as shareholder reports, company governance, financial data, capital and shares, operational overview, and financial summaries. The length is substantial (15,000 characters) and contains comprehensive financial and operational information typical of a full annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-10-07 Chinese
108年年報及股東會資料 — 2020_3164_20200630F05.pdf
Annual Report Classification · 95% confidence The document is a detailed record of a shareholders' meeting of 景岳生物科技股份有限公司 held on June 30, 2020 (Republic of China year 109). It includes attendance details, reports on the 108th fiscal year (2019) business operations, financial statements, profit distribution proposals, amendments to company bylaws, election of directors, and other shareholder resolutions. The document contains voting results for each agenda item and detailed attachments such as the annual business report, financial statements, audit reports, and amendments to governance documents. The presence of detailed financial data, management reports, and comprehensive discussion of company operations and governance indicates this is the full Annual Report document rather than just an announcement or a summary. It is not a simple announcement of voting results or a proxy statement, but a full report including financials and management discussion. Therefore, the appropriate classification is Annual Report (10-K). FY 2019
2020-10-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.